Lomé, August 12, 2026 — West Africa faces a defining choice: continue relying on imported medicines or forge its own path toward pharmaceutical self-sufficiency. This pivotal question brought together medical and academic leaders from across the region on Wednesday at the Agora Senghor in Lomé, where the groundwork was laid for a complete overhaul of West Africa’s healthcare strategy during the 21st edition of the Federation of West African Pharmacy Students (FESPAO) Scientific and Cultural Conference.
The event marked a turning point. No longer content with mere budgetary appeals, the region’s emerging medical elite is demanding a fundamental shift in doctrine. The era of the pharmacy as a mere distribution outlet is fading; in its place, industrialization, genomic research, and the scientific validation of traditional knowledge are taking center stage.
Local production as a matter of national security
The global pandemic and recent supply chain disruptions have exposed a harsh truth: Africa’s heavy reliance on imported pharmaceuticals is not just an economic burden—it’s a critical national security vulnerability. This was the core argument advanced during the summit.
Professor Gado Tchangbédji, Togo’s Minister Delegate for Higher Education and Research, outlined the government’s bold new direction under President Faure Essozimna Gnassingbé: positioning innovation and domestic pharmaceutical production as the region’s first line of defense against future health crises. To achieve this, the state is committing to robust support for scientific collaboration and applied research initiatives.
The promise of genomic epidemiology and ancestral wisdom
Yet local production alone won’t suffice if it merely replicates foreign patents without adaptation. True sovereignty demands therapies tailored to Africa’s unique genetic landscape—a reality long overlooked in global clinical trials. The Lomé conference placed genomic epidemiology at the heart of the conversation, highlighting an urgent scientific priority: developing treatments aligned with the genetic makeup of African populations.
This forward-thinking approach is paired with a deliberate embrace of cultural heritage. Experts are advocating for the industrial valorization of traditional pharmacopeia. No longer should herbal medicine remain an informal practice; instead, it must undergo rigorous clinical trials to unlock and patent entirely new active compounds rooted in African traditions.
Redefining the role of the pharmacist
However, this ambitious vision confronts a critical human capital challenge. If the sector is to evolve, academic training must keep pace. Professor Tchin Darré, Togo’s Minister Delegate for Health and Dean of the Faculty of Health Sciences at the University of Lomé, identified the linchpin of this transformation: curriculum reform. Tomorrow’s West African pharmacist cannot be confined to dispensing pills behind a counter. Instead, they must emerge as cutting-edge researchers, industry leaders, and specialists in validating indigenous knowledge systems.
As discussions in Lomé enter their final phase, the conference’s goal is clear: convert these academic deliberations into enforceable public policies that sever West Africa’s dependence on distant manufacturing hubs. The stakes could not be higher. Without a robust local pharmaceutical industry and research ecosystem rooted in African realities, the region will remain vulnerable to external supply shocks—risks that future pandemics could magnify. True healthcare sovereignty will be measured by the continent’s ability to translate these resolutions into tangible action, ensuring every patient has access to medicines designed, tested, and produced within Africa.
